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The OralCDx is a preliminary screening tool developed to identify suspicious lesions.  Despite 
large numbers of persons diagnosed with oral cancers annually, minimal research has been 
conducted on the efficacy and utilization rates of OralCDx.  The purpose of this study is to 
determine perceived efficacy and utilization rates of OralCDx nationwide.  A 16-item survey was 
used to survey a random sample of 100 dentists and a 6-item survey was used to survey a random 
sample of 400 patients.  Data analyses were conducted using frequencies, cumulative 
frequencies, percents, analysis of variance, and tests of chi-square using the JMP program.  
Preliminary results revealed that 54% of the dentists had high/extremely high confidence in the 
accuracy of the results.  Preliminary results revealed 81% of the patients reported no pain 
involvement with OralCDx.  It can be concluded form this study that OralCDx is accepted by 
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 Oral cancer is a disorder involving malignant tissue growth in the oral cavity.  Different 
cancers can develop from individual types of cells.  Depending on the types of cells involved and 
the extent of neoplasmic growth, oral lesions are diagnosed as benign or malignant.  Diagnosis is 
important because it influences patient treatment options and outlook for recovery.  Some oral 
cancers display symptoms that cause patients to seek medical attention; however, most oral 
cancers do not cause symptoms until they have reached an advanced stage.  Treatment varies 
widely depending on many variables that include location, type, and stage of the cancer at the 
time of diagnosis. Some oral cancers require localized surgical excision, while others may 
require extensive surgical removal that results in severe physical deformities with subsequent 
psychological consequences1.   
 Although the average at age diagnosis is 60, ninety five percent of oral cancer occurs 
primarily in adult males over 40 years of age2. Over 30,000 cases of oral cancers are diagnosed 
annually and result in over 8,000 deaths in the United States each year2.  Although early 
diagnosis has the best long-term prognosis, many oral cancers remain undiagnosed or are not 
diagnosed until a late stage.  Despite efforts to reduce oral cancer and high-risk behaviors, the 
stage at diagnosis has remained unchanged in the past 50 years2.  Over 25% of oral cancer 
victims have not used tobacco and have had no other known high-risk factors3.   
 The exact etiology of oral cancer is unknown.  Smoking tobacco, smokeless tobacco use, 
and heavy alcohol consumption are documented in the literature as high-risk factors associated 
with most cases of oral cancers.  These factors are frequently associated with poor dental and 
oral hygiene.  
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Regular dental exams are vital for early detection of oral cancer and especially oral pre-
cancers.  Two well-known lesions identified as precancerous lesions in the oral cavity are 
leukoplakia and erythroplakia.  Leukoplakias are white, slightly raised areas that are not likely to 
be malignant.  At the initial diagnosis, approximately 5% of leukoplakias are cancerous.  If 
leukoplakias are improperly treated, they have an increased risk of progressing into cancer within 
ten years.  Erythroplakias are slightly raised reddish areas that cannot be scraped off.  Fifty-one 
percent of erythroplakias are diagnosed as cancer at the initial biopsy4.  Incisional biopsy is 
required to determine final diagnosis and to determine if oral lesions are diagnosed as benign or 
malignant. 
 The large numbers of persons diagnosed annually with oral cancers may be identified 
earlier by a new screening technique called the OralCDx brush biopsy. However, there is limited 
information available concerning the efficacy and utilization of the OralCDx brush biopsy in 
screening suspicious oral lesions at an early stage.  Since oral cancer has the best prognosis when 
diagnosed early, it is vital to determine the utilization and efficacy of the OralCDx brush biopsy 
by dental professionals.  It has been surmised that many dental professionals monitor suspicious 
lesions or directly refer patients to a specialist to perform incisional biopsies.  Although the 
OralCDx brush biopsy is being researched as a less invasive means of screening for oral cancer, 
it does not eliminate the need for the more invasive incisional biopsy for final diagnosis.  
 The purpose of this research was to determine nationally, the utilization and perceived 
efficacy of the OralCDx brush biopsy by dental professionals who have performed the biopsy 
and patients who have received the biopsy.  Perceived efficacy is defined as the dentists’ 
identification of lesions for the OralCDx brush biopsy, performance of the biopsy, confidence 
with the results, and attitudes related with these experiences. 
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STATEMENT OF THE PROBLEM: 
Limited research has been performed concerning efficacy of the OralCDx brush biopsy, 
and furthermore no research has been published on professional and patient acceptance. 
 
SIGNIFICANCE OF THE STUDY: 
 It is documented in the literature that persons having an early diagnosis and intervention 
of pre-cancerous and cancerous oral lesions at an early stage have a better overall long-term 
prognosis as compared to persons having undiagnosed or advanced stage diagnosis of oral 
lesions.  The lack of early detection may be attributed to lack of annual oral cancer screening 
examinations, minimal patient understanding of the early signs and symptoms of oral cancers, 
and popularity of high-risk behaviors and habits, including environmental factors.  Persons 
having an early diagnosis of oral cancer have an 80% chance of five-year survival1. Late stage 
detection of oral lesions can lead to dramatic physical and psychosocial post surgical 
consequences1.  
In order to avoid this problem, numerous methods have been suggested.  The OralCDx 
brush biopsy is the newest technique.   Dentists and dental hygienists may be more apt to use the 
OralCDx brush biopsy due to minimal patient discomfort.  No research has been published 
concerning the utilization and efficacy of the OralCDx brush biopsy technique.  Because the 
OralCDx brush biopsy is designed for early screening and detection, it is vital to determine the 
efficacy and utilization rate of this screening tool in order to promote health and longevity. 
 The purpose of this study is to determine the professional perceptions of efficacy and 
professional utilization rates of the OralCDx brush biopsy and to determine patient perceptions 
involved in the procedure.  Perceptions, utilization, and perceived efficacy will be evaluated by 
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dental professionals who have performed the OralCDx brush biopsy and by patients who have 
received the biopsy. 
 The results will provide information about the usefulness and necessity of using the 
OralCDx brush biopsy as a screening tool in order to detect oral cancers at an early stage.  The 
results will help determine the perception of professionals as to whether or not there is an 
association between using the OralCDx brush biopsy and accurate early detection of suspicious 
oral lesions.  If there is an association, then education about utilizing the OralCDx brush biopsy 
by dental professionals will help to further emphasize the importance of early oral cancer 
detection in a less invasive manner. 
 
QUESTIONS TO BE ANSWERED: 
1. Is there an association between the number of dentists who have high/extremely high 
confidence in the OralCDx brush biopsy and the number of biopsies they have 
performed? 
 
2. Is there an association between dental offices that have dental hygienists performing 
OralCDx brush biopsies and the location of the dental office? 
 
3. Is there an association between dentists who feel that all suspicious lesions should 
have OralCDx brush biopsies and the number of biopsies that have reported 
positive/abnormal results? 
 
4. Is there an association between the number of years a dentist has practiced dentistry 
and his/her confidence level in the accuracy of the results of the OralCDx brush 
biopsy? 
 
5. Is there an association between the number of positive/abnormal results and where the 
information for the OralCDx brush biopsy was obtained? 
 
DEFINITION OF TERMS: 
Biopsy/Incisional Biopsy- removal of tissue for microscopic diagnosis 
 
Screening- preliminary procedure to determine if further treatment is needed 
 
Non-invasive- a procedure that does not require the skin to be broken 
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Exfoliative Cytology- scraping cells on the surface of tissue for microscopic diagnostic 
purposes. 
 
Suspicious Oral Lesion- any abnormal epithelial lesion in the mouth that would not be selected 
for immediate histologic exam.  
 
Benign- localized tumor having well differentiated cells that do not invade surrounding tissues 
or metastasize.   
 
Malignant- anaplastic, invasive that tends to spread and end in death. 
 
Sensitivity- quality of the ability to detect 
 
Specificity- quality of being distinctive 
 
Positive- showing disease 
 
Negative- showing absence of disease 
 
False-Negative- showing no detection of disease when disease is present 
 
False-Positive- showing the presence of disease when no disease is present 
 
International TNM System of  
Classification of Oral 
Carcinomas:5    T, Size of tumor 
T1s, Carcinoma in situ 
     T1, Tumor < 2 cm in size 
     T2, Tumor > 2 cm to < 4 cm in size 
     T3, Tumor > 4 cm in size 
T4, Massive tumor with deep invasion into bone, 
      muscle, skin, etc. 
 
     N, Regional lymph node involvement 
     N0, No palpable nodes 
     N1, Single, homolateral palpable node < 3 in 
      diameter 
     N2, Single, homolateral palpable node, 3 to 6 cm, or 
       multiple, homolateral nodes, none > 6 cm 
     N3, Single or multiple, homolateral nodes, one > 6 
       cm, or Bilateral nodes, or contralateral nodes 
 
     M, Metastases 
     M0, No known metastasis 
     M1, Distant metastasis 
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International TNM System for  
Staging Of Oral Carcinomas:5  I T1, N0, M0 
      II T2, N0, M0 
      III T3, N0, M0 
       T1, T2, or T3, N1, M0 
      IV Any T, N2, N3, M0 
       Any T, any N, M1 
 
ASSUMPTIONS: 
1. Dental professionals perform the OralCDx brush biopsy with correct technique and 
proper training. 
 
2. Patients may not be aware of the significance of their oral condition and the 
availability of diagnostic techniques. 
 
3. In compliance with the researcher’s requests, the Medical Director of OralScan 
Laboratories Inc. randomly selected participants, sent surveys, received, reviewed, 
and tabulated results. 
 
4. Patients want any screenings/biopsies performed to provide accurate results. 
 
5. The OralCDx is a professionally accepted non-invasive screening tool.  
 
LIMITATIONS: 
1. The researcher did not have complete control over the dentist and patient selection 
and explanation of high-risk behaviors/habits, patient survey mailing, receiving, or 
tabulation of results. 
 
2. No follow-up survey will be distributed to determine final diagnosis. 
 
3. Participants included only those dentists already familiar with the procedure. 
 
DELIMITATIONS: 
1. Dentists selected for this study must have performed the OralCDx brush biopsy on a 
minimum of one patient. 
 
2. Patients selected for this study must have received at least one OralCDx brush biopsy 
procedure on a suspicious lesion. 
 
3. Participants in this study must be 18 years of age or older. 
 










 “Oral cancer is a common disorder that is associated with significant morbidity and 
mortality.  Because it often goes undiagnosed, treatment options are limited and prognosis is 
affected”6.  Approximately 30,000 cases of oral cancers are diagnosed annually7.  Despite 
technological advances, “at stage diagnosis has not changed significantly in the past decade”2.  
Early detection and diagnosis includes patient education, annual oral cancer screening 
examinations by dental professionals, and eliminating patients’ high-risk behaviors and habits. 
 
ETIOLOGY OF ORAL CANCERS 
 In 1998, the Center for Disease Control (CDC) reported an estimated 30,300 diagnosed 
cases of oral cancers.  “Approximately 8,000 deaths (5,200 males and 2,800 females) are 
expected each year.  Ninety-five percent of oral cancer cases occur among persons aged over 40 
years, and the average age at diagnosis is 60 years”2. High-risk behaviors and habits put patients 
at risk for developing oral cancers.  High risk behaviors and habits include smoking cigarettes, 
pipes, or cigars, consuming large amounts of alcohol, use of smokeless tobacco, and 
environmental and lifestyle habits that include exposure to sunlight and diet.  Tobacco smoking 
and heavy alcohol consumption (over 30 drinks per week) are primary risk factors for developing 
oral cancers and account for 75% of oral cancers in the United States2. Oral cancers arising from 
primary high-risk behaviors can be prevented through tobacco cessation and decreasing alcohol 
consumption.  The remaining 25% of oral cancers are of unknown origin3.  The literature states 
that 36% of persons have localized disease, 43% of persons have regional disease, and 9% of 
persons have distant disease at the time of diagnosis2. Early diagnosis and detection of oral 
cancers is vital for long-term prognosis and longevity.  “The five-year survival rate for persons 
8 
having oral cancers is 81% for those with localized disease, 42% for patients with regional 
disease, and 17% for those with distant metastases”. Over ninety percent of oral cancers are 
diagnosed as squamous cell carcinomas2.  Boyle, Macfarlane, and Scully state that physicians, 
dentists, and pharmacists, should have the knowledge of early detection of oral lesions and the 
importance of seeking advice from a specialist.  Education and behavior modifications are still 
the primary preventions for oral cancers.  “When a person stops smoking, the risk of oral cancer 
drops to that of a lifelong non-smoker after five to ten years after smoking cessation”8 
 
RISK FACTORS OF ORAL CANCERS 
“Smoking, a once socially accepted behavior, is the leading cause of preventable death 
and disability in the United States”9. Risk factors for cancers of the mouth include tobacco and 
alcohol use, sun exposure, increase in age, and previous history of cancer.  Smoking alone 
accounts for 75% of all oral cancers in the United States2. A 1994 study was performed to 
evaluate the relation of smoking and alcohol consumption to the development of secondary 
tumors in high-risk groups.  Patients having high-risk behaviors with the occurrence of 
secondary tumors were selected over a one-year period.  Eighty patients were selected who 
displayed secondary tumors and the control group involved 189 patients who did not display 
secondary tumors.  Results indicated that tobacco smoking and alcohol consumption contributed 
to the risk of secondary tumors.  Smoking had more pronounced effects than alcohol 
consumption.  Oral and pharyngeal cancers occurred in patients having the largest amounts of 
alcohol and smoking intakes10. The combination of smoking with alcohol usage has strong 
synergistic actions that increase oral cancer risk.  Mucci and Brooks telephone surveyed 2119 
Massachusetts adults aged 35 and older with a long smoking history in order to identify if these 
persons were less likely to visit the dentist annually.  Compared to persons without either risk 
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factor, those who were at higher risk from both long-term smoking and low fruit and vegetable 
consumption were even less likely to visit the dentist compared to persons without either risk 
factor.  Also, the number of persons seeking annual exams decreased while their smoking 
duration and amount smoked per day increased11.  Bouquot and Meckstroth demonstrated that 
although West Virginia had the highest per capita consumption of smokeless tobacco, it had less 
oral and pharyngeal cancers than the United States average.  Results showed that average annual 
oral and pharyngeal cancer incidence in West Virginia males and females was 13.4 and 5.1, 
respectively, compared to the United States average of 15.4 and 5.7 (per 100,000 population) 
during 1950 - 198012. 
 
ORAL CANCER PREVENTION 
It has been well documented in literature that oral cancer, if diagnosed at an early stage, 
has the best prognosis.  Oral cancer can be identified as a lifestyle disease and, therefore, is 
primarily preventable.  According to Diamond, et al. early detection and treatment of oral cancer 
is often successful, however, most cancers are detected at a late stage.  As a result, late stage 
diagnosis leads to major physical and psychosocial morbidity, and poor prognosis.  ‘The past 
four years has driven to raise the profile of the prevention, and more specifically, the early 
detection of oral cancer’1 Literature by Downie, et al. states that prevention of oral cancer and its 
impact on an individual have four focal points: 
1. Reduce and avoid the risk of developing the illness 
 
2. Focus on early diagnosis and effective treatment to restore health 
3. Prevent complications associated with the disease and treatment 
4. Prevent re-occurrence 
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By targeting these four focal points focus needs to be centered around reducing oral cancer risk 
factors while simultaneously emphasizing advantages of early oral cancer detection and 
treatment.  It must also indicate that diagnosis of cancer does not have to be a death sentence1.  
The importance of communicating to the population of prevention and early intervention is 
implacable.  Johnson and Warnakalusuriya state that Health promotion campaigns for oral cancer 
have been primarily based on the broad population, yet research indicates that activities should 
target high-risk groups rather than the population as a whole. Client-centered activities are more 
sensitive to factors that influence individual readiness to change.   Patients must be reached at a 
personal level in order to intervene with behaviors such as smoking cessation, reducing alcohol 
consumption, and utilizing dental services1. Although the United States government has 
established public awareness about the risks of using tobacco and alcohol, it cannot be 
guaranteed that public behavioral changes will follow.  In 1997 the National Institute of Dental 
Research of the National Institute of Health and the American Dental Association held a 
conference concentrating on oral and pharyngeal cancer prevention, treatment, and research, 
from both public and private sectors.  Participants at the conference developed recommendations 
concerning advocacy, collaboration, and coalition building; public education, professional 
education and practice; and data collection.  The ten strategies selected for priority 
implementation included the following:   
1. Establish a mechanism to implement and monitor the recommended strategies 
developed during the conference 
 
2. Urge oral health professionals to become more actively involved in community health 
 
3. Require instruction in preventing and controlling tobacco and alcohol use at all levels 
of training in dental, medical, nursing, and other related health-care disciplines 
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4. Encourage Medicaid, Medicare traditional insurance plans, and managed-car entities 
to consider making oral cancer examinations an integral part of comprehensive 
physical and oral examinations 
 
5. Designate federal funding for a national program of oral cancer prevention, early 
detection, and control 
 
6. After assessing local needs, develop, implement, and evaluate statewide models to 
educate all relevant groups 
 
7. Develop and conduct a national promotional campaign to raise public awareness of 
oral cancer and its link to tobacco use and heavy alcohol consumption 
 
8. Develop health-care curricula that require competency in prevention, diagnosis, and 
multidisciplinary management of oral and pharyngeal cancer 
 
9. Sponsor and promote continuing education for health-care professionals on the 
multidisciplinary management of all phases of oral cancer and its siquelae 
 
10. Strengthen organizational approaches to reducing oral cancer by developing 
organized cooperative and collaborative arrangements, funding formal centers, and 
involving commercial firms 
 
The strategies will be used by the Centers for Disease Control and Prevention (CDC) to develop 
programs to reduce the burden of oral and pharyngeal cancer in the United States2.  A study of 
251 fourth year dental students at three Texas dental schools were surveyed about their attitudes 
and perceptions of their knowledge and skills in areas related to oral cancers.  A 16-item survey 
contained questions related to prevention, detection, diagnosis, and management of oral cancer 
and oral cancer therapy methods.  A 79% response rate was received.  Over half of the students 
had observed a biopsy of oral tissue or read a report.  However, only one-fourth had actually 
performed the procedure.  Most respondents felt they were comfortable with their skills in 
counseling patients about oral cancer risk factors and most felt they were comfortable identifying 
a malignant lesion.  Almost all respondents had been taught full head and neck examinations.  
Eighty-four percent were comfortable with their skills in performing these evaluations13. 
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Many changes in the oral cavity occur in the retromolar area that is out of normal view for the 
patient. 
 
ORAL CANCER SCREENING 
It is well established that when oral cancer is diagnosed early, prognosis and treatment 
options are more positive.  Education, annual examinations, and reduction of high-risk behaviors 
increase the ability of detecting oral cancer at an early stage.  Two abnormal lesions identified as 
precancerous lesions in the oral cavity are leukoplakia and erythroplakia.  Leukoplakias are 
white, slightly raised areas that are not likely to be malignant.  Approximately 5% of 
leukoplakias are cancerous at initial diagnosis or, if not treated properly, have an increased risk 
of progressing into cancer within ten years.  Erythroplakias are slightly raised reddish areas that 
cannot be scraped off.  Fifty-one percent of erythroplakias are diagnosed as cancer at the initial 
biopsy4.  However, incisional biopsy is required to determine final diagnosis.  
Oral exfoliative screening techniques are being utilized to determine cytology of 
suspicious oral lesions.  It has been argued that only a small number of cells are evaluated in a 
cytologic smear, and therefore, it is not a valuable screening tool.  The OralCDx brush biopsy 
was developed to identify lesions that warrant further diagnostic evaluation. A study involving 
190 participants was conducted to determine the efficacy of exfoliative cytology in the detection 
of oral premalignant and malignant lesions.  A cytologic diagnosis of the lesions was compared 
to histopathologic diagnosis of the same lesions.  Ninety-one participants were clinically 
diagnosed as a leukoplakia, 59 were clinically diagnosed as a squamous cell carcinoma, and 40 
were clinically diagnosed as normal tissue.  The results showed a 77% specificity, 100% 
sensitivity, and 92% accuracy for those first clinically diagnosed as having leukoplakia.  
Squamous cell carcinoma displayed a sensitivity of 94%, specificity 100%, and 95% accuracy 
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for those first diagnosed as squamous cell carcinoma.  In conclusion, oral exfoliative cytology 
was determined to be a useful method for detecting oral premalignant and malignant lesions14. 
Oral exfoliative cytology does not replace the need for excisional biopsy as definitive diagnosis.  
 A study involving 945 patients was performed to evaluate the sensitivity and specificity 
of the OralCDx brush biopsy.  This biopsy uses computer-assisted analysis to determine the 
cytology of pre-cancerous and cancerous lesions.  The study included a double-blind population 
with patients displaying both suspicious lesions and non-suspicious lesions. An OralCDx brush 
biopsy was performed on all lesions.  Following the OralCDx results, a scalpel biopsy was 
performed on all lesions having a positive or abnormal result with OralCDx. Results showed that 
the OralCDx independently detected every histologically confirmed oral dysplasia and 
carcinoma showing sensitivity = 100% and the false-negative rate = 0%.  The results confirmed 
that each positive result was a dysplasia or carcinoma.  The results showed 100% specificity for 
the  “positive” results and showed 92.9% specificity for “atypical” results.  The OralCDx brush 
biopsy found 4.5% of the “benign-looking” lesions to be dysplasia or carcinoma15. This study 
included no scalpel biopsies on negative lesions.   
 
ORALCDx 
 From June 2000 to June 2001, over 40,000 dentists have incorporated OralCDx into their 
practices16.  Each OralCDx package includes an instructional video on the performance of the 
biopsy, 3 OralCDx test kits, a patient education tabletop display and brochures, and a laminated 
guide to lesions.  The test kit includes:  a sterile brush biopsy instrument, a bar-coded specimen 
slide, 2 fixative packets, a slide holder, a bar-coded test requisition form, complete instructions, 
and a postage-paid return mailing box.  Indications for using the OralCDx brush biopsy include 
the following: 
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1. red, white, or mixed lesions 
2. chronic ulcerations 
3. lesions with unusual surface changes such as a granular appearance 
4. evaluation of mucocutaneous disorders 
5. follow-up of a persistent lesion despite a benign diagnosis 
6. patients with a history of oral or other head and neck cancer and who have evidence 
of mucosal change17. 
 
OralScan Laboratories, Inc. includes a step-by-step guide for performing the biopsy.  
Performing the biopsy includes the following steps:  
1. Moisten the brush with the patient’s saliva. 
 
2. Press the biopsy brush firmly into the lesion, turn the brush 5-10 times until 
microbleeding occurs. 
 
3. Spread the cellular sample from the biopsy brush to the slide including as much 
sample from the brush as possible. 
 
4. Pour fixative immediately onto slide and let sit for 15 seconds, then place it in the 
slide holder and mail the slide to OralScan Laboratories, Inc. 
 
Dentists are facsimiled the results within 3 days after the specimen is received by the laboratory.  
A screened summary of the representative cellular abnormalities and a pathologist’s report is 
mailed to the dentist for all lesions with positive or abnormal results.  These images enable the 
dentist to explain the abnormal test results to the patient and substantiate the need for further 










METHODS AND MATERIALS 
  
 In November 2001, a 16-question, three page survey (see Appendix C) was mailed 
through the United States Postal Service to 100 dentists nationally. These dentists were eligible 
to receive this survey because they had performed a minimum of one OralCDx brush biopsy.  In 
January 2002, a 6-question survey (see Appendix D) was sent to 400 patients who received the 
OralCDx brush biopsy.  These sample populations (dentists and patients) were chosen to survey 
because of their personal experience utilizing or receiving the OralCDx brush biopsy 
respectively.   
 The survey was mailed to 100 dentists, randomly selected from the database of OralScan 
Laboratories Inc.  The names and addresses of the sample populations were sent to the researcher 
from the Medical Director of OralScan Laboratories Inc. The contact information was destroyed 
following the completion of the mailing.  Surveys did not include any codes to track results 
because there would be no second mailing.  The sample of 400 patients was randomly selected 
from the database of OralScan Laboratories Inc.  In order to maintain complete patient 
confidentiality, the surveys were sent to the patients directly from the company, returned to, and 
interpreted by OralScan Laboratories Inc.  The company sent the results to the researcher.  
Results cannot be tracked, therefore, eliminating the possibility of a second mailing. 
 A cover letter (see Appendix B), a pre-stamped addressed envelope, and a fake $1 million 
bill, enclosed as a humorous gesture, were included with each dentist mailing.  The cover letter 
explained that the survey was being conducted in partial fulfillment of the requirements for a 
Master of Science degree in Dental Hygiene from West Virginia University School of Dentistry.  
The purpose of this survey was stated, participants were advised that the survey was voluntary, 
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and instructions were provided which included the length of time to answer the survey.  
Confidentiality was explained and a response deadline of December 20, 2001 was requested. 
 The 16-item survey for dentists included both multiple choice and completion questions. 
Questions included demographics, where OralCDx was learned, who performed the biopsy in 
their office, criteria to perform the biopsy, confidence in the biopsy, number of biopsies 
performed, percent of biopsies that returned positive or abnormal, and follow-up procedures. 
 The 6-item patient survey included multiple choice and likert scale questions.  Content of 
the questions included high-risk behaviors and habits, understanding of the biopsy procedure, 
amount of pain felt during the biopsy, fear of the results, and cessation of high-risk behaviors and 
habits following the biopsy. 
 Completed surveys were requested to be returned within four weeks from the date they 
were mailed.  At the December deadline, a response rate of 71 (71%) of the dentist surveys and 
256 (64%) of the patient surveys was returned.  No second mailing was attempted because there 
was no alternative to track responses received.  Data analyses were conducted using the JMP 
program and included frequencies, cumulative frequencies, percents, analysis of variance, and 




 Dentist survey.  All (100%) of the dentists who responded had performed a minimum of 
one OralCDx brush biopsy, with the majority (73%) performing 11 or more biopsies.  Figure 1 
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Most of the dentists expressed the opinion that all suspicious lesions should be screened 
with the OralCDx brush biopsy. Figure 2 shows the distribution of dentists who felt that the 























The majority of the dentists had practiced dentistry for 11 or more years, with over half 
practicing in suburban areas. General dentists followed by Oral and Maxillofacial Surgeons most 
often included this biopsy procedure in their practices.  Figures 3, 4, and 5, respectively, 
represent the number of years the participants had practiced dentistry, the location of their 
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Figure 5.  Dentists' Type of Practice (n=68)
21 
Dentists had performed most of the biopsies, followed by dental hygienists, and dental 
























The top four criteria selected for biopsy by respondents included the presence of a 
leukoplakia or erythroplakia (83%), the patient with high-risk behaviors and habits (79%), the 
clinical characteristics of the lesion (68%), and the length of time the oral lesion had been 
present in the mouth (47%). Dentists felt that performing a biopsy on a patient may positively 
motivate that individual to eliminate his or her high-risk behaviors and habits.   Figure 7 shows 


























 The majority (74%) of the participants had high or extremely high confidence in the 
accuracy of the results of the OralCDx brush biopsy.  Figure 8 displays the levels of confidence 























Of the brush biopsies performed by the dentists responding to this survey, less than 20% 
exhibited positive or abnormal results.  Figure 9 represents the percentage of positive or 
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Figure 9.  Dentists' Positive/Abnormal Biopsy Results (n=71)
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When positive or abnormal results did occur, the most common follow-up method was to 
call the patient and schedule and in-office appointment (49%), followed by a direct referral to a 
specialist (29%).  Less than half of the dentists surveyed (44%), performed follow-up procedures 
that included a direct call to inform the patient of negative lab results following biopsy.  Almost 
all of the dentists reported that they continued to monitor oral lesions that returned with negative 
results.  Figure 10 represents the percentage of dentists that continued to monitor oral lesions that 



















Patient survey.  Of the patients surveyed, less than half felt that they had no high-risk 
behaviors or habits that put them at risk for developing oral cancer(s).  Figure 11 summarizes the 
patients’ perceptions of having high-risk behaviors and habits that put them at risk for 














Figure 11.  Do Patients' Personal Habits Put Them at Risk for 









The high-risk behaviors and habits included cigarette smoking (73%), chewing tobacco 
(13%), poor oral hygiene (4%), not visiting the dentist (1%), cheek biting (1%), alcohol use 
(7%), and smoking pipe and smoking cigars (1%).   Only (4%) n=10 of the patient respondents 
reported changing their behavior and habits after undergoing a biopsy procedure.  Eight of those 
individuals stopped smoking (one of which discontinued multiple forms of tobacco) and two 
ceased their chewing tobacco habit. 
Patients had a complete perceived understanding of why they needed to have a biopsy.  
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The great majority (88%) of the patients were not fearful that the results of the biopsy 












Figure 13.  Was the Patient Fearful that Their Biopsy Result 







Patients overwhelmingly reported minimal to no pain involvement with the biopsy.  
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Almost all (99%) of patients who received the biopsy would recommend the procedure to 










 Figure 15.  Would Patients Recommend this Procedure







 The study design did not allow statistical comparison between the patient and dentist 
survey results.   Widespread utilization of the OralCDx brush biopsy does exist and the 
procedure is perceived to be efficacious due the broad level of acceptance by both the dentist and 
patient.   
 Although the criteria for screening with OralCDx is clearly stated by OralScan 
Laboratories, Inc., the majority of participants (Figure 2) felt that the OralCDx should be used 
for all suspicious lesions.  This data may be misrepresented due to the participants’ 
misunderstanding of the question or the participants not understanding the specific guidelines 
related to lesion identification for performing the OralCDx brush biopsy. 
 Participant demographics (Figures 3, 4, and 5) described them as primarily general 
dentists who are seasoned in their field and are largely located in suburban areas.  The 
investigator speculates that this may be due to the fact that many seasoned professionals may 
read their professional journals more readily and pursue continuing education.  Whereas newer 
dentists in the field may not have been trained in this technique if it was not discussed in their 
dental schools.  The OralCDx has not been introduced into dental school settings to this point. 
 While the dentist performs the OralCDx brush biopsy most often (Figure 6), few dentists 
stated that this task was relegated to dental hygienists in their dental offices. The low number of 
dental hygienists who were reported to be performing this minimally invasive procedure, may be 
the result of the varying state practice acts in each state that mandates the expanded functions 
that a dental hygienist is permitted to perform.  The literature that involves early detection of oral 
cancer is extensive.  Since the dental hygienist is the first oral care provider to interview and 
examine the patient, suspicious oral lesions can be detected early and the minimally invasive 
OralCDx brush biopsy can subsequently be performed.  The investigator suggests that more 
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patients may be reached with early oral cancer techniques by allowing dental hygienists to 
perform the minimally invasive OralCDx brush biopsy. 
 The majority of dentists, according to the results, selected the top four criteria that 
indicated biopsy including the existence of a leukoplakia or erythroplakia, the patient with high-
risk behaviors or habits, clinical characteristics of the lesion, and the length of time the oral 
lesion had been present in the mouth.  These criteria are included in the oral lesion selection that 
permits the utilization of the OralCDx brush biopsy by OralScan Laboratories, Inc. 
 The results showed that less than half of the dentists felt that OralCDx provided positive 
motivation to patients, and a small subset of patients could be motivated both positively and 
negatively (Figure 7).  The investigator projects that the positive motivation is due to patients 
proactively being made aware that they are at risk and educating them about steps that could be 
taken toward changing habits and behaviors, while negative motivation could instill fear or 
neglect in the patient in which no action would be taken to promote their health. 
 Although no statistical association was found between the high numbers of OralCDx 
brush biopsies performed and the high confidence rate dentists had in the procedure, it should be 
noted that dentists are very confident in the accuracy of the biopsy results (Figure 8).  The high 
confidence that dentists had in the OralCDx brush biopsy exemplifies the need for more dental 
professionals to be made aware of this procedure in order to detect oral cancers at the earliest 
possible stage with an accurate, minimally invasive screening tool. 
Results of this study showed that almost all (Figure 10) of the dentists continued to 
monitor oral lesions that were found to have a negative result with OralCDx.  This is 
commendable due to the fact that at this point, no literature exists concerning the results of a 
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scalpel biopsy in conjunction with the OralCDx brush biopsy to identify the specificity and 
sensitivity for negative oral lesions with the OralCDx brush biopsy.   
Although, over 25% of oral cancer victims have not used tobacco and had no other 
known high risk factors3, results revealed that over half of the patients surveyed perceived 
themselves as having no high-risk habits or behaviors that put them at risk for developing oral 
cancers (Figure 11).  This could have resulted due to the fact that the investigator did not have 
complete control of the patient selection, or it could have resulted from the patients’ perception 
of what high-risk factors include. 
Results showed that almost all of the patients surveyed felt that they had complete 
understanding of the procedure and why they needed a biopsy (Figure 12).  Although no 
literature exists to support this claim, the investigator speculates that this finding could be 
attributed to the overall understanding of the procedure by the dentist and their ability to explain 
it to their patient, the faith the patient had in the doctor’s understanding of the procedure, the 
patient not understanding the survey question, or because of the patient not wanting to admit a 
lack of understanding. 
The majority of the patients surveyed were not fearful of the results of their biopsy 
(Figure 13).  This could be attributed to the patients’ complete understanding of their need for 
the biopsy and the procedure involved.  Having a complete understanding about the procedure 
they will experience and what the biopsy screens for may put the patient at ease and reduce their 
fear of a positive OralCDx brush biopsy. 
 Perhaps the highest level of acceptance was the recommendation of the procedure to a 
friend or family member.  Having a complete understanding of the procedure, minimal to no pain 
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involvement, no fear of the results, and having no perceived high-risk behaviors or habits could 
all contribute to the patients’ support of the OralCDx brush biopsy. 
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SUMMARY AND CONCLUSION 
Based on the data collected, literature reviewed, and the investigator’s experience, the 
OralCDx brush biopsy 1) is an accepted screening tool by both dental professionals and patients, 
2) is used with frequency by those professionals who had performed the procedure it at least 
once, 3) is minimally invasive in nature, 4) is relatively easy to use, 5) is a time efficient tool, 6) 
is accurate in providing results according to published literature, and 7) appears to be a technique 
that could be performed by dental hygienists.   Therefore, education about the utilization and 
efficacy should be shared among dental professionals and their patients in order to promote 
health and longevity.  From this study, the following may be concluded: 
1. Both dentist and patient have confidence in the efficacy of the OralCDx brush biopsy. 
 
2. Patients understand why the OralCDx brush biopsy is necessary in the early detection 
of suspicious oral lesions. 
 
3. Patients did not experience pain involvement associated with the OralCDx brush 
biopsy. 
 
4. Dentists and patients would recommend the OralCDx brush biopsy to their family or 
a friend. 
 
5. The OralCDx brush biopsy is utilized by a variety of dental professionals. 
 







1. In order to determine sensitivity and specificity of OralCDx, a study should be designed to 
screen for both positive and negative lesions with the OralCDx brush biopsy followed by 
incisional biopsy. 
  
2. The OralCDx brush biopsy should be incorporated into general and oral pathology courses to 
enable health science students to gain knowledge of the procedure, use, and indication for 
OralCDx as a minimally invasive screening for suspicious oral lesions. 
 
3. A subsequent study should be conducted that involves dentist and patient perceptions of 
OralCDx efficacy and utilization after the procedure is more established by overall dental 
professionals. 
  
4.  A survey should be developed to compare a stratified random sample of dentists who have 
performed the OralCDx brush biopsy, with dentists who have not performed the OralCDx, in 
order to gain understanding of perceived efficacy and utilization of the procedure by both 
groups. 
 
5. A study should be conducted nationally to determine the professional efficacy and utilization 
by dental hygienists that have performed a minimum of one OralCDx brush biopsy. 
 
6.   For this study, the researcher recommends a larger randomly stratified dentist and     patient 
sample size and a list of high-risk behaviors to be included on the patient survey to enable the 
patient to select each high-risk behavior that they have in order to minimize subjectivity. 
 
7.    The name OralCDx brush biopsy may need to be re-evaluated in order to allow dental 
hygienists to perform this procedure according to the guidelines associated with insurance 
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